Viewing data from:

FENOFIBRIC ACID

ANDA

CHOLINE FENOFIBRATE | A208705 | ALEMBIC PHARMACEUTICALS LTD

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 2 NDCs

Highest NADAC/Unit

$0.2548

per ea

Lowest NADAC/Unit

$0.1683

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
62332024590FENOFIBRIC ACID DR 135 MG CAP	$0.2548	EA	Generic	—	2026-10-21
62332024490FENOFIBRIC ACID DR 45 MG CAP	$0.1683	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs3 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

CORDEN PHARMA CHENOVECHOLINE FENOFIBRATE DRUG SUBSTANCE

DMF 209502007

OLON SPACHOLINE FENOFIBRATE

DMF 232682009

CURIA MISSOURI INCCHOLINE FENOFIBRATE

DMF 233902009

OLON SPACHOLINE FENOFIBRATE

DMF 234642010

ALIVUS LIFE SCIENCES LTDCHOLINE FENOFIBRATE

DMF 245242011

MOEHS IBERICA SLCHOLINE FENOFIBRATE

DMF 245402011

HARMAN FINOCHEM LTDCHOLINE FENOFIBRATE

DMF 282822014

ABBVIE INCInactiveCHOLINE FENOFIBRATE DRUG SUBSTANCE

DMF 208952007

ABBVIE INCInactiveCHOLINE FENOFIBRATE MINI-TABLET INTERMEDIATE

DMF 208962007

LUPIN LTDInactiveCHOLINE FENOFIBRATE

DMF 230482009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 45MG FENOFIBRIC ACID

0 patents0 exclusivities▴

CAPSULE, DELAYED RELEASE;ORAL | Approved: May 12, 2017

No patent or exclusivity listings for this strength.

#002 — EQ 135MG FENOFIBRIC ACID

0 patents0 exclusivities▾

CAPSULE, DELAYED RELEASE;ORAL | Approved: May 12, 2017